Original Biomedicals Co Ltd

Original Biomedicals Co Ltd

TTPEX:6483
13.30
TWD
-0.50
(-3.62%)
935.31MMarket Cap

Total Valuation

TWD

As of June 30, 2026, Original Biomedicals Co Ltd carries a market capitalization of 935.31M, placing it among publicly traded companies globally. Its enterprise value stands at 873.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap935.31M
Enterprise Value873.70M

Share Statistics

As of June 30, 2026, Original Biomedicals Co Ltd has 66.81M shares outstanding.

Shares Outstanding66.81M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio8.43
P/TBV Ratio8.47

Financial Position

As of June 30, 2026, Original Biomedicals Co Ltd maintains a current ratio of 7.02, meaning it holds 7.0x the short-term assets needed to cover near-term liabilities.

Current Ratio7.02
Quick Ratio4.28
Debt / Equity8.25

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count15.00

Stock Price Statistics

TWD

As of the close on November 17, 2026, Original Biomedicals Co Ltd's stock has gained approximately 35.71% over the past 52 weeks. The 50-day moving average sits at 13.26, while the 200-day moving average is 14.05.

52-Week Price Change35.71%
50-Day Moving Average13.26
200-Day Moving Average14.05

Balance Sheet

TWD

As of June 30, 2026, Original Biomedicals Co Ltd holds 70.77M in cash and equivalents against 9.16M in total debt, resulting in a net debt position of -60.76M. Total book value stands at 110.95M, with working capital of 99.49M providing operational flexibility.

Cash & Cash Equivalents70.77M
Total Debt9.16M
Net Debt-60.76M
Equity (Book Value)110.95M
Book Value Per Share1.66
Working Capital99.49M